K. Shinozuka et al., Effect of 9-(6,7-dideoxy-beta-D-allo-hept-5-ynofuranosyl)adenine on noradrenaline release from vascular sympathetic nerves, CLIN EXP PH, 28(4), 2001, pp. 312-314
Citations number
14
Categorie Soggetti
Pharmacology & Toxicology
Journal title
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
1. The effects of 9-(6,7-dideoxy-beta -D-allo-hept-5-ynofuranosyl)- adenine
(HAK2701), a selective and potent ligand for P3 receptor-like protein, on
the release of endogenous noradrenaline (NA) from electrically stimulated r
at mesenteric artery and rabbit ear artery were compared with those of a nu
mber of purinoceptor agonists.
2. In the fat mesenteric artery, the pi receptor agonists 2-chloroadenosine
(2CA) and 5'-N-ethylcarboxamidoadenosine (NECA) and the P2 purinoceptor ag
onists beta,gamma -methylene ATP (beta gamma mATP) and 2-methylthio ATP (2m
SATP) significantly inhibited the release of NA in a xanthine-sensitive man
ner. HAK2701 did not significantly inhibit the release of NA, the relative
order of potency being beta gamma mATP > NECA > 2CA > 2mSATP >> HAK2701.
3. In the rabbit ear artery, both pi and P2 receptor agonists significantly
facilitated the release of NA in a xanthine-sensitive manner. HAK2701 also
significantly facilitated the release of NA, the relative order of potency
being HAK2701 > beta gamma mATP > 2CA > 2mSATP > NECA.
4. These findings suggest that HAK2701 may be a potent and selective agonis
t for facilitatory prejunctional purinoceptors, but not for inhibitory puri
noceptors, on adrenergic nerve terminals.